JPRN-UMIN000008871
Completed
未知
clinical study of positron emission tomography with 3-deoxy-3-[18F]-fluoro-D-glucose - Clinical study in 3FDG-PET
Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata0 sites100 target enrollmentSeptember 7, 2012
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- healthy adult volunteer, cancer, epilepsy, Moyamoya disease,Alzheimer'
- Sponsor
- Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •exclude the patients who are recognized as inadequate patients by doctors with resposibility in this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study using positron emission tomography(PET)brain tumor,epilepsy,multiple sclerosis, neuromyelitis,Duchenne musclar dystrophy,Alzheimer's disease,Down Syndrome,HydrocephalusJPRN-UMIN000005626Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata100
Completed
Not Applicable
Clinical relevance of Positron Emission Tomography (PET) imaging following endovascular aneurysm repair using the Nellix endoprosthesis.Abdominal aortic aneurysmenlarged artery of the abdominal aorta10002363NL-OMON40667Rijnstate Ziekenhuis10
Completed
Not Applicable
Imaging study using positron emission tomography with AV-45 for dementiaJPRN-UMIN000003608ippon Medical School75
Completed
Not Applicable
Imaging study using positron emission tomography for the effect of nootropics on the athletic performancehealthy adultsJPRN-UMIN000004907ippon Medical School15
Active, not recruiting
Phase 1
Study of the positron emission tomography (PET) tracer for tau 18F-PI-2620 in individuals with Down syndromeEUCTR2019-004634-41-ESInstitut de Recerca HSCSP80